✦ LIBER ✦

Models of acute myeloid leukemia: Prospects for drug development and testing

✍ Scribed by Bin Yin; David A. Largaespada

Book ID: 119225717
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 205 KB
Volume: 3
Category: Article
ISSN: 1740-6757
DOI: 10.1016/j.ddmod.2006.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of targeted therapies for ac

Development of targeted therapies for acute myeloid leukemias

✍ Salmon, Jessica; Bots, Michael; Verbrugge, Inge; Martin, Ben; Stanley, Kym; Bake 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Development of donor cell derived acute

Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia

✍ Pieroni, F; Oliveira, F M; Panepucci, R A; Voltarelli, J C; Simões, B P; Falcão, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Prediction of remission in adult acute l

Prediction of remission in adult acute leukemia. Development and testing of predictive models

✍ Terry L. Smith; Edmund A. Gehan; Michael J. Keating; Emil J Freireich 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Modeling of In Vitro Drug Activity and P

Modeling of In Vitro Drug Activity and Prediction of Clinical Outcome in Acute Myeloid Leukemia

✍ Quartino, Angelica; Karlsson, Mats O.; Freijs, Agneta; Jonsson, Niclas; Nygren, 📂 Article 📅 2007 🏛 Sage Publications 🌐 English ⚖ 165 KB

Acute myeloid leukemia developing during

Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities

✍ Attaphol Pawarode; Sheila N.J. Sait; Alain Nganga; Lionel J. Coignet; Maurice Ba 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 171 KB

The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been

Development of secondary skull sarcoma a

Development of secondary skull sarcoma after treatment for childhood acute myeloid leukemia

✍ Makoto Ohno; Yoshitaka Narita; Yasuji Miyakita; Yoshiko Okita; Takamasa Kayama; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 895 KB